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LETTERS TO THE EDITOR 
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in typewritten form , double-spaced, a nd are not to exceed 2'12 pages. When appropriate, we will solicit com-
ments from the original authors. All Letters to the Editor are subject to editing and possible abridgment. 
REGIONAL VARIATION OF IMMUNOGLOBULIN DEPOSITS 
IN NZB/ W FI MICE: A TAIL-END SUGGESTION. 
" ... we do fear this body hath a tail/ more perilous than the head." 
W. S hakespeare 
(in Cymbeline iv-2-144) 
T o the Editor: 
We found the article by Drs. Sontheimer and Gilliam (J Invest 
Dermalot 72:25-28, 1979) on the regional variation of subepidermal 
immunoglobulin (subepi-Ig) deposits in the NZB/ W FI mouse well 
done and interesting. Of special note was their finding that subepi-Ig 
was present on the keratinizing, hair-bearing surface of mouse lip, and 
its complete absence under the mucosal surface. They hypothesize that 
at the mucosal surface, the DNA antigen becomes " unavailable to react 
with DNA antibodies at the D-E junction" s ince the epithelia l ce lls 
t hat. are shed at the mucosal surface stili contain their nuclei and take 
the DNA with them [1). 
Epidermal cytoplasmic antibodies (ECA) have been linked to kera-
tinization an.d presumably can detect distinctly different cytoplasmic 
molecules in keratinocytes "programmed" for mucous, parakeratotic or 
orthokeratotic differentiation. Therefore, the target antigens for ECA 
seem to be molecules involved in keratinocyte differentiation (2). Mol-
ecules may change their antigenic characteristics depending upon the 
type and stage of keratinization in the cell. Further, t here is some 
evidence to suggest that in certain situations, intracellular molecules 
(antigens), other than DNA, may be deposited into the basement 
membrane zone at the D-E junction (3). Cytoplasmic proteins and 
antibodies to these cytoplasmic proteins have also been described in 
systemic lupus erythematosis [4]. 
S ince ther NZB/W FI mice were already injected with tritium-
la beled thymidine and biopsies taken from the lip, back and abdomen, 
it would have been interesting if they had obtained, as well, a biopsy 
from the tail for their direct immunofluorescent studies; for in that 
location there are a lternating bands of parakeratotic and orthokeratotic 
epidermis [5]. It would have been additionally interesting if they had 
tested the sloughed epidermal cells from the parakeratotic ta il region 
with ethidium bromide marker for the presence of DNA along with 
measuring the basal cell labeling indexes of these tail bands that have 
the same blood supply, same cephalic-caudal position and the same 
tissue consistency. 
Assuming that DNA antigen is sloughed from the parakeratotic ta il 
region and is therefore unavailable at the D-E junction, these additional 
procedures would have confirmed their results, strengthened their 
hypothesis and helped to exclude factors such as skin texture, skin 
thickness, skin glycogen content and tissue water content that could 
influence the observed differences between mucosal and parakera totic 
skin. 
If their observations held true for the tail region, but there was no 
significant parakeratotic sloughing of DNA in the tail, one would 
assume that the DNA antigen is available at the D-E junction and the 
observed differences in mucosal and parakeratotic subepi-Ig deposit ion 
are due to some other cause. 
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REPLY 
We wish to thank Drs. Woodley and Prunieras for their thoughtful 
and constructive suggestion and reply simply that the tale of the tail 
has yet to be to ld. 
Richard D. Sontheimer, M.D. 
James N. Gilliam, M.D. 
CHRONIC TRICHOPHYTON RUBRUM INFECTION AND 
BLOODGROUPS 
T o the Editor: 
Drs. Young and Roth state in their article (Immunological Cross-
reactivity between a Glycoprotein Isolated from Trichophyton menta-
, grophytes and Human Isoant igen A, 72: 46-51,1979) that cross-reacting 
antigens from the mycelia l cell wall of T. menta.grophyles, T. rllbrllm 
and E. (toccoslim and human isoantigen A, may be a factor leading to 
chronic infection. They suggest that clinical studies on patients with 
chronic mycotic infections should include bloodgroup typing. 
In our series of 25 chronicaUy with T. rllbrum infected patients, 20 
belonged to the Royal Netherlands Navy personnel, so their blood-
groups could easily be traced. This group of patients was defined as 
follows. (1) A recorded duration of infection of more than 5 yr. (2) 
Immediate-type skin reactions to trichophytins in all patients, some 
which had concurrent delayed-type reactions. (3) Absence of so li tary 
de layed type skin reactions to trichophytins. (4) Normal skin response 
to other recall antigens. (5) Significantly more atopy and (6) signifi-
cantly more recurrences in a 2-3 year follow-up period, compared to 
noninfected pa tients and a group of patients with a acute T . rllbrllrrt 
infection (H. Neering and J . C. van der Horst, to be published) . 
The distribu t ion of the bloodgroups in these 20 patients was: A, 8 
(40%); B, 3 (15%); and 0 , 9 (45%). Rhesus-D pos were: 18 (90%) and 
Rhesus-D neg were 2 (10%). This distribution is essentially similar to 
the occurrence of bloodgroups and Rhesus factors in the Netherlands 
popula tion (A, 41 , 8%; B, 8.5%, AB, 3.0%; 0, 46.7%, Rhesus-D pos: 84% 
and Rhesus-D neg: 16%). 
We are, therefore, unable to add clinical evidence to the interesting 
findings ill the article mentioned above. 
Dr. H. Neering 
Dept. Dermato-Venereology 
Roya l Neth. Navy Hospita l 
Overveen 
Netherlands 
TYROSINE HYDROXYLATION 
To the Editor: 
In their article, Drs. Shapiro, Edelstein, Patel, Okun et al [1] pub-
lished some rather questionable conclusions based on data which might 
seem convincing to those not familiar with the field, and which I feel 
need some clru·ification. In their paper, they claimed their da ta sup-
ported the notion that mammalian tyrosinase (EC 1.14.18.1) was inca-
pable of tyrosine hydroxylation as determined by the tritiated water 
assay developed by Pomerantz [2]. There are a variety of papers in the 
literature, some of ours included, which have shown purified mamma-
lian tyrosinase to be capable of tyrosine hydroxyla tion, not only via the 
Pomerantz assay, but by several other types of methodologies as well 
[3-7]. Space does not allow a full critique of the paper-however, the 
inabili ty of the S hapiro group to confum th is may be due to one or 
more of the following considerations: 
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